Abiopharma

🔍 Lane Nick (Executive)

Company: Equitable Holdings, Inc. (EQH)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 314 shares of Common Stock (Direct)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 124,929.88 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs, and vest proportionally with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock.
• F2: Total includes RSUs.
• REMARKS: Reporting person's title is President of Equitable Financial